Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade
The Schnitzler syndrome (SCS) is a rare, late-onset acquired autoinflammatory syndrome often underdiagnosed. The diagnosis is based on the Lipsker and recently on validated Strasbourg diagnostic criteria (chronic urticarial rash, monoclonal gammopathy, intermittent fever, arthritis, arthralgia, bone...
Main Authors: | Paola Faggioli, Antonio Tamburello, Lucia Roncoroni, Antonino Mazzone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | Clinics and Practice |
Subjects: | |
Online Access: | https://www.clinicsandpractice.org/index.php/cp/article/view/1018 |
Similar Items
-
Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab
by: S O Salugina, et al.
Published: (2017-11-01) -
A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
by: Yuya Fujita, et al.
Published: (2021-03-01) -
Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome
by: Shelly Pathak, et al.
Published: (2020-12-01) -
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
by: Jerold Jeyaratnam, et al.
Published: (2018-03-01) -
Schnitzler’s syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström’s disease
by: FS van Leersum, et al.
Published: (2019-06-01)